Clinical Trials Logo

Clinical Trial Summary

In total 50 patients diagnosed with long-segment infrapopliteal arterial disease will be randomized in two groups. The patients randomized in the Drug coated balloons (DCB) study arm will undergo a percutaneous transluminal angioplasty (PTA) with the use of a paclitaxel-coated balloon, while the patients randomized in the drug-eluting stent (DES) study arm will undergo primary stenting using drug-eluting stent(s). The study's primary endpoints will be the 6-month angiographic binary restenosis rate. Secondary endpoints will include the immediate technical success,6-month primary patency, target lesion revascularization and limb salvage and complication rates.


Clinical Trial Description

Patients programmed to undergo PTA due to angiographically-proven infrapopliteal arterial disease in our department will be randomized in the above mentioned study arms. The studies primary endpoint will be assessed with the use of intra-arterial digital subtracted angiography and subsequent Quantitative Vascular Analysis (QVA) analysis.Clinical follow-up is set at 1, 3 and 6 months. Patients' baseline demographics and procedural details will be recorded and analyzed. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01517997
Study type Interventional
Source University of Patras
Contact
Status Completed
Phase Phase 2/Phase 3
Start date August 2011
Completion date September 2013

See also
  Status Clinical Trial Phase
Completed NCT02228564 - BARD® Study of LIFESTREAMâ„¢ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease N/A
Withdrawn NCT01002209 - Postoperative Hyperbaric Oxygen Treatments to Reduce Complications in Diabetic Patients Undergoing Vascular Surgery Phase 2/Phase 3
Completed NCT02255188 - Experimental Study of the Vascular Prosthesis Manufactured by Electrospinning N/A
Terminated NCT00913900 - Safety Study of Adult Stem Cells to Treat Patients With Severe Leg Artery Disease Phase 1
Completed NCT01548378 - Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia Phase 2
Completed NCT00447889 - A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR) Angiography Phase 4
Terminated NCT00823225 - Urokinase Therapy in Patients With Diabetic Foot Syndrome Phase 3
Terminated NCT00403780 - Randomized Study of Pregabalin for Pain Reduction in Patients With Rest Pain and Lower Limb Ischemia Phase 4
Completed NCT00817349 - Angio-Seal Evolution Device Registry
Completed NCT00673985 - Edwards Lifesciences Self-Expanding Stent Peripheral Vascular Disease Study N/A
Active, not recruiting NCT02685098 - A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation Phase 1
Completed NCT00352222 - Safety and Efficacy of Express LD to Treat Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries Phase 3
Completed NCT00153166 - ARREST PAD (Peripheral Arterial Disease) Phase 2/Phase 3
Completed NCT00115856 - Imaging of Plaque With Magnetic Resonance Imaging (MRI) N/A
Completed NCT00537498 - Urokinase Therapy in Diabetic Foot Syndrome Phase 2
Completed NCT01746550 - A Safety and Effectiveness Study of the MD-12-001 Stent in the Treatment of Superficial Femoral Artery or Popliteal Artery Blockages in Japanese Patients N/A
Withdrawn NCT00407940 - ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion Phase 4
Completed NCT00489320 - An Observational Registry Using Drug Eluting Stents (DES) in Patients in a Real-World Setting (DEScover Registry). N/A
Completed NCT00189540 - Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers Phase 2
Recruiting NCT04275323 - Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1) Phase 3